Vad är ett kliniskt symtom

1.Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al.

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the europeisk samhälle of Cardiology. Eur Heart J 2005;26(11):1115-40.
2.Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival.

J Card Fail 2000;6(3):225-32.
3.Friedman MM. Older adults\' symptoms and their duration before hospitalization for heart failure. Heart & Lung 1997;26(169-76).
4.Nordgren L, Sorensen S. Symptoms experienced in the gods six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2003;2(3):213-7.
5.Zambroski CH, Moser DK, Bhat G, Ziegler C.

Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs 2005;4(3):198-206.
6.Rogers A, Addington-Hall JM, McCoy AS, Edmonds PM, Abery AJ, Coats AJ, et al.

ex

A qualitative study of chronic heart failure patients\' understanding of their symptoms and drug therapy. Eur J Heart Fail 2002;4(3):283-7.
7.Ekman inom, namn A. Fatigue in chronic heart failure, does gender man a difference? Eur J Cardiovasc Nurs 2003;1:77-82.
8.Lynn J, Teno JM, Phillips RS, Wu AW, Desbiens N, Harrold J, et al. Perceptions bygd family members of the dying experience of older and seriously ill patients.

SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern tillsammans med 1997;126(2):97-106.
9.Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The gods six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000;48(5 Suppl):S101-9.
10.Falk K, Swedberg K, Gaston-Johansson F, Ekman inom.

Fatigue and anaemia in patients with chronic heart failure.

Symtom och kliniska fynd

Eur Heart J Fail. 2006;8:744-9.
11.Brostrom A, Stromberg A, Dahlstrom U, Fridlund B. sova difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 2004;19(4):234-42.
12.Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of nedstämdhet to increased fara of mortality and rehospitalization in patients with congestive heart failure.

båge Intern tillsammans 2001;161(15):1849-56.
13.Falk K, Swedberg K, Gaston-Johansson F, Ekamn inom. Fatigue fryst vatten a prevalent and severe symptom associated with uncertainty and sense of coherence in patients with chronic heart failure. Eur J Cardiovasc Nurs. 2006;6:99-104.
14.Skotzko CE, Krichten C, Zietowski G, Alves L, Freudenberger R, Robinson S, et al.

nedstämdhet fryst vatten common and precludes accurate assessment of functional ställning eller tillstånd in elderly patients with congestive heart failure. J Card Fail 2000;6(4):300-5.
15.Russell SD, McNeer FR, Higginbotham MB. Exertional dyspnea in heart failure: a symptom unrelated to pulmonary function at rest or during exercise.

Duke University Clinical Cardiology Studies (DUCCS) Exercise Group.

Hjärtsvikt är ett kliniskt syndrom med varierande sjukdomsbild

Am Heart J 1998;135(3):398-405.
16.Shah MR, Hasselblad V, Stinnett SS, Kramer JM, Grossman S, Gheorghiade M, et al. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 2002;4(3):297-304.
17.Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger titta. Distinguishable types of dyspnea in patients with shortness of breath.

Am Rev Respir Dis 1990;142(5):1009-14.
18.Mahler DA, Harver A, Lentine T, Scott JA, Beck K, Schwartzstein RM. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care tillsammans med 1996;154(5):1357-63.
19.Elliott MW, Adams L, Cockcroft A, MacRae KD, Murphy K, Guz A. The language of breathlessness. Use of verbal descriptors bygd patients with cardiopulmonary disease.

Am Rev Respir Dis 1991;144(4):826-32.
20.Gadsboll N, Hoilund-Carlsen PF, Nielsen GG, Berning J, Brunn NE, scen P, et al. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;10(11):1017-28.
21.Tiesinga LJ, Dijkstra A, Dassen TW, Halfens RJ, van den Heuvel WJ.

Are nurses able to assess fatigue, exertion fatigue and types of fatigue in residential home patients? Scand J Caring Sci 2002;16(2):129-36.
22.Fonseca C, Morais H, Mota T, Matias F, revben C, Gouveia-Oliveira A, et al.

The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail 2004;6(6):795-800, 821-2.
23.Ekman J, Kjörk E, Andersson B. Self-assessed symptoms in chronic heart failure – important for clinical management. Eur J Heart Fail. 2006;9:424-8.
24.Hogg K, Swedberg K, McMurray J. Heart Failure with Preserved Left Ventricular Systolic Function.

J Am Coll Cardiol 2004;43:317-27.
25.Zile M, Baicu C, Gaasch W. Diastolic Heart Failure-Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle. N Eng J tillsammans med 2004;350:1953-9.
26.Redfield M, Jacobsen S, Burnett J, Mahoney D , Bailey K et al. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community. JAMA 2003;289:194-202.
27.Izzo JL, Gradman AH.

Mechanisms and management of hypertensive heart disease from left ventricular hypertrophy to heart failure. tillsammans med Clin North Am. 2004 Sep;88(5):1257-71.
28.Kass DA. Mechanisms and efficacy of LV pre-excitation for patients with heart failure and supranormal systolic function.

Symtom och klinisk bild är snarlik den vid HFrEF (se Hjärtsvikt, kronisk – med reducerad systolisk funktion (HFrEF, HFmrEF och HFimpEF)) och det finns ingen möjlighet att skilja formerna åt enbart med hjälp av klinisk bedömning

Heart Fail Rev 2000;5(4):357-65.
29.Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004;2594(12):1533-42.
30Kamisago M, Sharma SD, DePalma SR, Solomon S, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Eng J tillsammans 2003;343(23):1688-96.
31.Fatkin D, Graham RM.

Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002;82(4):945-80.
32.Johnson R, Srinivas T, Cade R, Rideout B, et al. Uric Acid, Evolution and Primitive Cultures.

Klinisk undersökning och diagnostik innefattar att tolka patientens anamnes (sjukhistoria) samt fynden (kliniska tecken) från den kroppsliga undersökningen och uttrycka detta i en diagnos eller ett sjukdomstillstånd

Semin Nephrol 2005; 25:3-8.
33.Johnson R, Feig D, Herrera-Acosta J, Kang D-H. Resurrection of Uric Acid as a Causal fara Factor in Essential Hypertension. Hypertension 2005;45:18-20.
34.Johnson R, Segal M, Srinivas T, Ejaz A, et al. Essential Hypertension, Progressive renal Disease and Uric Acid: A Pathogenetic Link? J Am Nephrol 2005;16:1909-19.
35.Feig D, Nakagawa T, Karumanchi A, Oliver W, et al.

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International 2004;66:281-7.
36.Birchem JA, Fraley MA, Senkottaiyan N, Alpert MA. Influence of hypertenison on cadiovascular outcomes in hemodialysis patients.

Sammanfattning

Semin Dial 2005;18(5):391-5.
37.Jougasaki M, Burnett JC. Adrenomedullin: potential in physiology and pathophysiology. Life Sci 2000;66(10):855-72.
38.Yusuf S, Hawken S, Ounpuu S, Dans T, et al. Effect of potentially modifiable fara factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364(9438):937-52.
39.Candido R, Forbes J, Thomas M, Thallas V, et al.

A Breaker of Advanced Glycation End Products Attenuates Diabetes Induced Myocardial Structural Changes. Circulation Research 2003;92:785.
40.Zieman S, Kass D. Advanced glycation End Product Cross-Linking: Pathophysiologic Role and Therapeutic mål in Cardiovascular Disease. Congest Heart fail 2004;10;3:144-51.
41.Pascual M, Pascual DA, Soria F, Vicente T, et al.

Effects of isolated obesity on systolic and diastolic left ventricular function.

hosta eller andnöd), oklar bröst- eller skuldersmärta eller tillkomst av blodig hosta skall patienten helst remitteras för datortomografi av torax alternativt lungröntgen

Heart 2003;89(10):1127-9.
42.Kaplan N, Opie L. Controversies on hypertension. Lancet 2006;367:168-76.
43.Thohan V, Torre-Amione G, Koerner MM. Aldosterone antagonism and congestive heart failure: a new look at an old therapy. Curr Opin Cardiol. 2004 Jul;19(4):301-8.